Connection
Shuk-Mei Ho to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Shuk-Mei Ho has written about Xenograft Model Antitumor Assays.
|
|
Connection Strength |
|
|
|
|
|
0.139 |
|
|
|
-
Lam HM, Ouyang B, Chen J, Ying J, Wang J, Wu CL, Jia L, Medvedovic M, Vessella RL, Ho SM. Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer. Endocr Relat Cancer. 2014; 21(6):903-14.
Score: 0.117
-
Zhou Q, Ching AK, Leung WK, Szeto CY, Ho SM, Chan PK, Yuan YF, Lai PB, Yeo W, Wong N. Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma. Int J Oncol. 2011 Mar; 38(3):721-31.
Score: 0.023